NanoVibronix climbs on Canada approval for medical devices

ENvue Medical

30/03/2022 15:55

** Shares of medical device maker  NAOV.O  jump 28.1% to
$1.16, their highest since December 2021
    ** Stock eyes best day since August 2021, if gains hold
    ** Co says its pain management devices PainGuard and
UroGuard have been approved by Health Canada  urn:newsml:reuters.com:*:nBw5dKvQQa
    ** Ideal Medical International Ltd, one of NAOV's
international distribution partners, now can market and sell the
products as licensed medical devices in Canada
    ** PainShield delivers a localized ultrasound effect to
treat pain and induce soft tissue healing in a targeted area
    ** More than 37.4 mln shares of the Elmsford, New York-based
company have traded so far, ~15,371.2% of their 30-DMA volume of
~243,200 shares
    ** As of last close, stock had fallen ~13% YTD

 (Reporting by Devik Jain in Bengaluru)
 ((Devik.Jain@thomsonreuters.com; within U.S. +1 646 223 8780;
outside U.S. +91 80 6182 2062; ;))